The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

Jane L. Wang, David C. Limburg, Matthew J. Graneto, John R. Springer, Joseph Rogier Bruce Hamper, Subo Liao, Jennifer L. Pawlitz, Ravi G. Kurumbail, Timothy J. Maziasz, John J. Talley,

Bioorganic & Medicinal Chemistry Letters · 2010 · 335 citations · 5 references

DOIFull text

Open access

Concepts

References

5